[C:1]([NH:4][NH2:5])(=[O:3])[CH3:2].[Br:6][C:7]1[CH:16]=[CH:15][CH:14]=[C:13]2[C:8]=1[N:9]=[C:10]([NH:20][C:21]([CH3:24])([CH3:23])[CH3:22])[C:11]([C:17](O)=O)=[N:12]2.CCCP1(OP(CCC)(=O)OP(CCC)(=O)O1)=O>CCOC(C)=O>[Br:6][C:7]1[CH:16]=[CH:15][CH:14]=[C:13]2[C:8]=1[N:9]=[C:10]([NH:20][C:21]([CH3:23])([CH3:22])[CH3:24])[C:11]([C:17]1[O:3][C:1]([CH3:2])=[N:4][N:5]=1)=[N:12]2Acetic hydrazide (33 mg, 0.44 mmol) and 5-bromo-3-(tert-butylamino)quinoxaline-2-carboxylic acid (371a) (130 mg, 0.40 mmol) were combined in EtOAc (4 mL) to give a yellow solution. TEA (0.17 mL, 1.20 mmol) was added followed by 1-propanephosphonic acid cyclic anhydride (Aldrich; 50 wt. % solution in EtOAc, 0.59 mL, 1.00 mmol). The reaction was sealed and heated in an oil bath at 90° C. for 16 h. The reaction mixture was cooled to RT, partitioned between saturated NaHCO3 and EtOAc. The aq. layer was extracted with EtOAc and the combined organic layers were washed with brine, and the organic layer was dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The residue was adsorbed onto 1 g silica gel and purified by silica gel chromatography (12 g column) using a gradient of 0-20% EtOAc/hexanes to afford 8-bromo-N-(tert-butyl)-3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine (67 mg, 0.18 mmol, 46% yield) as a yellow solid. m/z (ESI, +ve ion) 362.0/364.0 (M+H)+.